Your browser doesn't support javascript.
loading
RET rearrangement-positive pancreatic cancer has remarkable response to pralsetinib: a case report.
Zhang, Tongyi; Wang, Hongwei; Cai, Zhiwei; Zhang, Siqi; Jiang, Chongyi.
Afiliação
  • Zhang T; Department of General Surgery, Huadong Hospital, Fudan University, Shanghai, China.
  • Wang H; Department of Hepato-Biliary-Pancreatic Surgery, Huadong Hospital, Fudan University, Shanghai, China.
  • Cai Z; Department of Hepato-Biliary-Pancreatic Surgery, Huadong Hospital, Fudan University, Shanghai, China.
  • Zhang S; The Medical Department, 3D Medicines Inc., Shanghai, China.
  • Jiang C; Department of General Surgery, Huadong Hospital, Fudan University, Shanghai, China.
Front Oncol ; 13: 1078076, 2023.
Article em En | MEDLINE | ID: mdl-37139148
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article